Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pretzel Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
Pretzel Therapeutics

Pretzel Therapeutics

Pretzel: A leading drug discovery company, leveraging expertise in mitochondrial biology.

HQ
Waltham, MA, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Pretzel Therapeutics was founded by leading academics in mitochondrial biology and is driven by a mission to develop life-changing medicines for patients and families affected by mitochondrial diseases. The company focuses on understanding and targeting the underlying causes of these diseases rather than just addressing symptoms. Pretzel Therapeutics leverages cutting-edge research in mitochondrial biology to discover and develop new treatments, aiming to create a new treatment paradigm in the field of mitochondrial therapeutics.

The company benefits from the leadership of experts in drug discovery, development, and company formation. Notable affiliated individuals include accomplished scientists and industry veterans who bring a wealth of experience to the organization. Pretzel Therapeutics has made significant strides in its field, contributing to a deeper understanding of mitochondrial diseases and advancing potential therapies. The impact of their work holds promise for improving the lives of thousands of people with genetic mitochondrial conditions.

Pretzel Therapeutics - Similar Companies

Lucy Therapeutics logo

Lucy Therapeutics

Stealth BioTherapeutics logo

Stealth BioTherapeutics

stealthbt.com

Mitochon Pharmaceuticals logo

Mitochon Pharmaceuticals

mitochonpharma.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Triplet Therapeutics logo

Triplet Therapeutics

triplettx.com

Vesalius Therapeutics logo

Vesalius Therapeutics

vesaliustx.com

MitoChem Therapeutics logo

MitoChem Therapeutics

mitocheminc.com

Petri Bio logo

Petri Bio

petribio.com

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Capacity Bio logo

Capacity Bio

capacitybio.com

RLS Therapeutics logo

RLS Therapeutics

Rectify Pharmaceuticals logo

Rectify Pharmaceuticals

rectifypharma.com

Resilience Therapeutics logo

Resilience Therapeutics

Alltrna logo

Alltrna

alltrna.com

Moma Therapeutics logo

Moma Therapeutics

Pretzel Therapeutics - Quick Facts

Who are Pretzel Therapeutics' competitors?

Companies similar to Pretzel Therapeutics include Lucy Therapeutics, Stealth BioTherapeutics, Mitochon Pharmaceuticals and ProFound Therapeutics.

When was Pretzel Therapeutics founded?

Pretzel Therapeutics was founded in 2019.

Where is Pretzel Therapeutics' headquarters located?

Pretzel Therapeutics' headquarters is located in Waltham, MA, US.

When was Pretzel Therapeutics' last funding round?

Pretzel Therapeutics' most recent funding round was for $72.5M (USD) in September 2022.

How much has Pretzel Therapeutics raised to-date?

As of Sep 12, 2022, Pretzel Therapeutics has raised a total of $72.5M (USD).

How many employees does Pretzel Therapeutics have?

Pretzel Therapeutics has 42 employees as of Feb 4, 2024.

Pretzel Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research